Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 DiabetesMartin Schön, Gidon J. Bönhof, Filippo Michelotti et al.|Diabetes|2023Cited by 11
<strong>Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes Mellitus</strong>Martin Schön, the GDS group, Oana‐Patricia Zaharia et al.|Unknown|2023Cited by 0
<strong>Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes Mellitus</strong>Martin Schön, the GDS group, Oana‐Patricia Zaharia et al.|Unknown|2023Cited by 0
Metabolische Phänotypen des Typ-2-Diabetes beeinflussen immunmetabolische Signaturen von zirkulierenden CD4+T-ZellenJacqueline M. Ratter-Rieck, Michael Roden, Alexandra Zepina et al.|Diabetologie und Stoffwechsel|2025Cited by 0